 BERKELEY HEIGHTS, N.J., Oct. 20, 2021 GLOBE NEWSWIRE -- CorMedix Inc. Nasdaq: CRMD, a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the acceptance for presentation of three abstracts at industry conferences. These include one abstract presented today at the Association of Managed Care Pharmacy AMCP Nexus conference in Denver, Colorado, and two abstracts being presented at the American Society of Nephrology ASN conference being held virtually November 4 8. 